Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2015

View Archived Issues

World Glaucoma Week: Novel agent is beneficial in model of intraocular hypertension

Northeastern University patents CB1 receptor modulators

CureVac patent describes antiviral combination vaccines

LG Life Sciences discloses necrosis and apoptosis inhibitors

Bioavailability studies support marketing applications for Bekinda

Taiho Pharmaceutical reports development of BTK inhibitors

FGFR and steroid hormone receptors could serve as thyroid cancer biomarkers

BMS-938790, a PEG-adnectin targeting hIL-23, for treatment of inflammatory diseases

SNP in TRMT11 gene described as potential biomarker in advanced-stage CRPC

Interleukin Genetics to provide genomic testing service for Isis phase I trial

University of Toronto divulges new anti-Frizzled antibodies

Bayer submits MAA for aflibercept for myopic choroidal neovascularization

Rotavac vaccine launched in India

Hua Medicine files IND in U.S. for HMS-5552

Alcobra's MDX meets primary endpoint in phase II trial in ADHD

Phase II trial of TKM-Ebola-Guinea starts in Sierra Leone

Dimethandrolone shows potential for male contraception

InMed Pharmaceuticals and University of Debrecen to develop cannabinoids for ocular allergy

Celgene gains access to Open Monoclonal Technology's OmniAb platform

Therapure cleared to begin phase I trial of TBI-304H for chemotherapy-induced anemia

Collegium raises financing to advance Xtampza ER to launch

Antibe Therapeutics resumes development of ATB-346 following review of phase I data

Zogenix sells Zohydro ER extended-release hydrocodone to Pernix Therapeutics

University of Tokyo and Sanofi collaborate in inflammatory diseases and oncology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...